Doctors, FDA Compliance and Production

A Thorny PMA Preemption Decision from Rhode Island

Drug & Device Law

MARCH 19, 2024

The manufacturer argued that it did not purposefully avail itself of the privilege of conducting business in Rhode Island because it manufactured a global product that it delivered to distributors who were responsible for marketing and selling the clips in the United States. So, both claims were expressly preempted. 3d 679 (D.N.J.

FDA

FDA FDA Compliance Trials FDA Approval

Drug Discovery Digest

A Thorny PMA Preemption Decision from Rhode Island

Webinars

Stay Connected